David Holt, IP Solicitor and Partner at Potter Clarkson, specialises in complex IP matters, including multi-jurisdictional agreements, spin-out arrangements, IP strategy, and due diligence, with expertise in biotechnology and therapeutics.
He advises on complex non-contentious IP matters, including drafting multi-jurisdictional agreements, negotiating spin-out arrangements involving intricate subject matter such as patentable inventions, and providing strategic IP guidance. Dave’s expertise extends to working with major public and private organisations, leading significant IP-focused due diligence projects for investors, including those investing in spin-out companies. While his practice has a particular focus on biotechnology, synthetic biology, cancer therapeutics, and novel therapeutics, he also handles IP matters across a broad range of complex technical fields.